Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 0.52 |
| ▸ | RAB9A | P51151 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20205543 | 1.00 | MAPT (0.52) | MAPTRAB9AALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL23678475 | 0.90 | MAPT (0.54) | MAPTRAB9AALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL20205929 | 0.90 | MAPT (0.54) | MAPTRAB9AALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL20205519 | 0.81 | MAPT (0.58) | MAPTRAB9AALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL24199471 | 0.81 | MAPT (0.58) | MAPTRAB9AALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL23678203 | 0.81 | ALDH1A1 (0.65) | MAPTRAB9AALDH1A1L3MBTL1RECQL | |
| SCHEMBL20205873 | 0.81 | ALDH1A1 (0.65) | MAPTRAB9AALDH1A1L3MBTL1RECQL | |
| SCHEMBL20205815 | 0.80 | SMN1; SMN2 (0.68) | MAPTRAB9AALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL23678214 | 0.80 | SMN1; SMN2 (0.68) | MAPTRAB9AALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL21098938 | 0.79 | MAPT (0.55) | MAPTRAB9AALDH1A1SMN1; SMN2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11225470-B2 | Tetrazolinone compounds and its use as pest control agents | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-01-18 | — | — | US | disclosed |
| EP-3544973-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PEST CONTROL AGENTS | SUMITOMO CHEMICAL CO (JP) | 2021-07-28 | — | — | EP | disclosed |
| WO-2018097318-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PEST CONTROL AGENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11225470-B2 | Tetrazolinone compounds and its use as pest control agents | CYC1, MT-CO1, CTRL | MAPT 3767/4885RAB9A 3323/4885ALDH1A1 1744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.